MACULAR EPIRETINAL BRACHYTHERAPY IN TREATED AGE-RELATED MACULAR DEGENERATION (MERITAGE)

201318 citationsJournal Article

Authors

Robert Petrarca · King's College London

Pravin U. Dugel · Retinal Consultants of Arizona

M. D. Bennett · Retina Institute of Hawaii

Adiel Barak · Tel Aviv Sourasky Medical Center

Dov Weinberger · Rabin Medical Center

Jeffrey Nau

Timothy L. Jackson · King's College Hospital

Abstract

The apparent reduction in ranibizumab retreatment was less evident in Year 2 than Year 1, with the moderate reduction in visual acuity extending into the second year. Although radiation retinopathy occurred in one case, it was not vision threatening and safety remained acceptable.

Topics & Keywords

Retinal Diseases and Treatments Retinal and Macular Surgery Glaucoma and retinal disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Retina

Volume 34, Issue 5, pp. 874-879

DOI: 10.1097/iae.0000000000000026

Field-Weighted Citation Impact: 3.34

Command Palette